TYK Medicines, Inc (HKG:2410)
Hong Kong
· Delayed Price · Currency is HKD 11.10
-0.09 (-0.80%)
Mar 10, 2026, 4:08 PM HKT
TYK Medicines Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 206.08 | 460.46 | 186.83 | 90.76 |
| Trading Asset Securities | 186.85 | - | 6 | 152.73 |
| Cash & Short-Term Investments | 392.93 | 460.46 | 192.83 | 243.49 |
| Cash Growth | 148.21% | 138.79% | -20.80% | - |
| Other Receivables | - | 3.47 | 1.79 | 1.86 |
| Receivables | - | 3.47 | 1.79 | 1.86 |
| Prepaid Expenses | 90.37 | 60.27 | 33.2 | 28.22 |
| Other Current Assets | - | 44.77 | 5.88 | 1.17 |
| Total Current Assets | 483.3 | 568.98 | 233.71 | 274.73 |
| Property, Plant & Equipment | 212.54 | 209.84 | 249.85 | 190.2 |
| Other Intangible Assets | 59.58 | 62.41 | 68.07 | 73.73 |
| Other Long-Term Assets | 37 | 74.47 | 21.51 | 19.71 |
| Total Assets | 794.42 | 915.69 | 573.14 | 558.36 |
| Accounts Payable | 14.15 | 19.64 | 32.17 | 9.66 |
| Accrued Expenses | 53.8 | 45.71 | 46.94 | 20.7 |
| Short-Term Debt | 130.86 | 144.18 | - | - |
| Current Portion of Leases | 25.61 | 26.19 | 22.23 | 23.49 |
| Current Income Taxes Payable | 0.01 | 6.98 | 0.46 | 2.05 |
| Other Current Liabilities | 34.91 | 46.39 | 1,199 | 906.33 |
| Total Current Liabilities | 259.33 | 289.08 | 1,301 | 962.24 |
| Long-Term Leases | 5.38 | 6.49 | 19.5 | 32.46 |
| Long-Term Unearned Revenue | 44.34 | 44.36 | 48.28 | 24.83 |
| Other Long-Term Liabilities | 118.87 | 103.21 | 84.41 | 39.58 |
| Total Liabilities | 435.92 | 443.13 | 1,453 | 1,059 |
| Common Stock | 370.84 | 370.84 | 307.36 | 287.99 |
| Additional Paid-In Capital | 1,481 | 1,481 | 768.34 | 602.71 |
| Retained Earnings | -1,508 | -1,396 | -1,009 | -626.67 |
| Comprehensive Income & Other | 13.18 | 13.18 | -951.08 | -769.97 |
| Total Common Equity | 356.91 | 469.09 | -884.48 | -505.94 |
| Minority Interest | 1.59 | 3.47 | 4.45 | 5.19 |
| Shareholders' Equity | 358.5 | 472.56 | -880.03 | -500.75 |
| Total Liabilities & Equity | 794.42 | 915.69 | 573.14 | 558.36 |
| Total Debt | 169.85 | 176.85 | 41.73 | 55.95 |
| Net Cash (Debt) | 223.08 | 283.62 | 151.1 | 187.54 |
| Net Cash Growth | 493.45% | 87.70% | -19.43% | - |
| Net Cash Per Share | 0.61 | 0.84 | 0.52 | 0.68 |
| Filing Date Shares Outstanding | 370.84 | 370.84 | 307.36 | 277.82 |
| Total Common Shares Outstanding | 370.84 | 370.84 | 307.36 | 277.82 |
| Working Capital | 223.97 | 279.89 | -1,067 | -687.51 |
| Book Value Per Share | 0.96 | 1.26 | -2.88 | -1.82 |
| Tangible Book Value | 297.33 | 406.68 | -952.55 | -579.67 |
| Tangible Book Value Per Share | 0.80 | 1.10 | -3.10 | -2.09 |
| Machinery | - | 19.95 | 18.63 | 17.03 |
| Construction In Progress | - | 143.38 | 139.17 | 65 |
| Leasehold Improvements | - | 21.13 | 15.38 | 8.87 |
Source: S&P Capital IQ. Standard template. Financial Sources.